Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/ab949ce3-26b3-431c-a4dd-11d58bbaf65f/

CBHD

Coloplast A/S
Chart
56.62 EUR
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.7w · Fresh
0.95
OS Score
97.0%
Value
92.0%
Quality
30.0%
Momentum
#82.00000000
TV Rank
6/9
F-Score
0.945
QV
Strategy Eligibility
8 of 23 passing
OS Composite
OS 0.950
Trending Value
Quality × Value
QV 0.945
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
P/E 6.0
VC2 Cheapest
VC2 7
📐
EBITDA/EV
24.8%
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
Rev +10%
🔄
Shareholder Yield
💰
High Yield
Div 5.4%
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
CAQ 0.59
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
97.0%ile
P/E
6.0×
P/S
0.5×
P/B
1.0×
E/P
0.2081
FCF Yield
0.125
EBITDA/EV
0.248
SH Yield
0.015
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
4.00000000
/100 — 1=cheapest
VC2 (Trending Value)
7.00000000
/100
VC3 (Buyback)
10.00000000
/100
P/E of 6.0x places this firmly in deep value territory. FCF yield of 12.5% is strong — the business generates significant free cash relative to price. VC2 score of 7.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
92.0%ile
ROE
0.167
ROA
0.046
Net Margin
0.076
Op Margin
0.267
GPA
0.405
Current
1.75
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.103
Earn Growth
0.053
Stability
1.453
lower=better
Accruals
-0.084
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
30.0%ile
6M Return
-19.1%
12M Return
-0.2%
12-1 Mom
-12.2%
Risk-Adj
-0.30
Vol 252d
40.3%
Vol 60d
97.1%
↑ Expanding
Max DD 12M
-32.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -12% signals a downtrend — price is moving against you. Near-term vol (97%) is expanding vs long-term (40%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.95
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 77 peers
Sector Value %ile
98.7%
Sector Quality %ile
87.2%
P/E z-score
-0.59
P/B z-score
-0.60
Sector Avg OS
49.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NOV Novo Nordisk A/S 98.0% 98.0% 83.0% 61.0%
MED MEDICLIN Aktiengesellschaft 98.0% 97.0% 82.0% 82.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 95.0% 58.0% 75.0%
M12 M1 Kliniken AG 95.0% 74.0% 92.0% 70.0%
DRW3 Drägerwerk AG & Co. KGaA 95.0% 90.0% 58.0% 74.0%
NN6 NanoRepro AG 93.0% 75.0% 70.0% 83.0%
DMP Dermapharm Holding SE 93.0% 68.0% 93.0% 74.0%
BRM Bristol-Myers Squibb Company 92.0% 63.0% 98.0% 76.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (97th) and quality (92th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Volatility Expanding
60-day vol (97%) significantly exceeds 252-day (40%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
88.3% avg (7 factors)
Quality
B
61.1% avg (7 factors)
Momentum
F
20.3% avg (4 factors)
Risk
C
49.6% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.950—7
Value %ile0.970—7
Quality %ile0.920—7
Momentum %ile0.300—7
F-Score6.000—0
Confidence0.910—7
Volatility0.403—2
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
5.95
Earnings Yield (E/P)
0.2081
Price / Sales
0.46
Price / Book
0.99
Price / Cash Flow
2.10
FCF Yield
12.5%
EBITDA / EV
24.8%
Sales Yield (1/P·S)
0.7799
Shareholder Yield
Div + net buyback / mktcap
1.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
16.7%
Return on Assets
4.6%
Net Margin
7.6%
Operating Margin
26.7%
Gross Profit / Assets
Novy-Marx GPA
40.5%
Current Ratio
1.75
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.084
MomentumPrice trend strength over different horizons
6M Return
-19.1%
12M Return
-0.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-12.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.30
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
10.3%
Earnings Growth (YoY)
5.3%
Earnings Stability (CV)
Lower = more stable
1.453
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
5.4%
Buyback Yield
-3.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
4
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
7
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
10
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
82
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity